Table 2.
Baseline and Postpartum levels of Angiogenic and oxidative biomarkers among the studied groups
| Parameters | NP | GH | PE | |||
|---|---|---|---|---|---|---|
| Pre-delivery | 48 h postpartum | Pre-delivery | 48 h postpartum | Pre-delivery | 48 h postpartum | |
| Angiogenic Factors | ||||||
| PLGF (pg/ml) | 137.7 | 187.9** | 53.05 | 163.9*** | 21.40 | 96.3*** |
| (88.1–177.8) | (130.7–214.6) | (38.33–74.80) | (94.00–200.3) | (12.40–48.40) | (77.3–131.0) | |
| sFlt-1 (pg/ml) | 119.5 | 45.6*** | 413.2 | 77.3*** | 787.6 | 104.6*** |
| (87.4–160.4) | (19.28–88.7) | (164.5–635.0) | (44.4–101.6) | (510.7–926.3) | (66.3–139.0) | |
| sFlt-1/PLGF | 0.9 | 0.2*** | 7.8 | 0.5*** | 36.80 | 1.1*** |
| (0.6–1.2) | (0.2–0.5) | (5.4–12.8) | (0.2–0.7) | (16.42–56.92) | (0.3–2.0) | |
| PLGF/sFlt-1 | 1.1 | 3.4** | 0.1 | 2.2*** | 0.0351 | 0.9*** |
| (0.5–2.0) | (1.9–9.5) | (0.1–0.5) | (1.0–3.7) | (0.015–0.085) | (0.5–1.7) | |
| Oxidative biomarkers | ||||||
| 8-epi-PGF2α (pg/ml) | 35.7 | 15.8** | 198.8 | 18.4*** | 324.6 | 66.3*** |
| (28.7–42.9) | (12.2–18.7) | (92.48–392.3) | (12.0–32.1) | (194.2–618.6) | (32.65–100.4) | |
| TAOC (mmol/l) | 1.1 | 1.2* | 0.6 | 0.8* | 0.5 | 0.7*** |
| (1.0–1.2) | (1.1–1.3) | (0.4–0.8) | (0.6–1.1) | (0.2–0.6) | (0.4–0.9) | |
Values are presented as median (Interquartile range). *p < 0.05; **p < 0.001; ***p < 0.0001